Russell Investments Group, Ltd. 4 D Molecular Therapeutics, Inc. Transaction History

Russell Investments Group, Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$12.64 - $19.76 $14,030 - $21,933	-1,110 Reduced 98.58%	16 $0
Q1 2023 May 09, 2023	SELL	$15.45 - $23.19 $6,844 - $10,273	-443 Reduced 28.23%	1,126 $19,000
Q3 2022 Nov 04, 2022	BUY	$6.96 - $11.48 $10,920 - $18,012	1,569 New	1,569 $12,000
Q2 2022 Jul 29, 2022	SELL	$5.68 - $15.99 $4,214 - $11,864	-742 Closed	0 $0
Q1 2022 May 05, 2022	SELL	$13.16 - $22.64 $739,552 - $1.27 Million	-56,197 Reduced 98.7%	742 $11,000

Q4 2021 Jan 21, 2022	SELL	$19.56 - $32.94 $895,417 - $1.51 Million	-45,778 Reduced 44.57%	56,939 $1.25 Million
Q3 2021 Nov 08, 2021	BUY	$22.73 - $36.04 $2.33 Million - $3.7 Million	102,717 New	102,717 $2.77 Million

157

50.3M

718K

370K

Ticker FDMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,382,400
Market Cap $666M
Description
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.